ReviewFrontiers in neurology2024
Neuroprotective effects of GLP-1 class drugs in Parkinson's disease.
Dongliang Lv et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it
ReviewFrontiers in neurology2024
Dongliang Lv et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.